T Regulatory Lymphocytes (Treg) Depletion for Cancer Treatment Efficacy and Safety Study (STARTREK)

Clinical Trial ID NCT00986518

PubWeight™ 3.09‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00986518

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Trial watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology 2012 1.33
2 Colorectal cancer and immunity: what we know and perspectives. World J Gastroenterol 2014 1.00
3 Antigen quality determines the efficiency of antitumor immune responses generated in the absence of regulatory T cells. Cancer Gene Ther 2010 0.82
Next 100